Amalgamated Bank’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-10,450
| Closed | -$712K | – | 3003 |
|
|
2022
Q3 | $712K | Buy |
10,450
+579
| +6% | +$39.5K | 0.01% | 1249 |
|
|
2022
Q2 | $315K | Sell |
9,871
-229
| -2% | -$7.31K | ﹤0.01% | 1682 |
|
|
2022
Q1 | $350K | Sell |
10,100
-688
| -6% | -$23.8K | ﹤0.01% | 1703 |
|
|
2021
Q4 | $316K | Buy |
10,788
+142
| +1% | +$4.16K | ﹤0.01% | 1796 |
|
|
2021
Q3 | $271K | Sell |
10,646
-656
| -6% | -$16.7K | ﹤0.01% | 1877 |
|
|
2021
Q2 | $396K | Buy |
11,302
+263
| +2% | +$9.22K | ﹤0.01% | 1762 |
|
|
2021
Q1 | $450K | Sell |
11,039
-959
| -8% | -$39.1K | 0.02% | 1044 |
|
|
2020
Q4 | $520K | Buy |
11,998
+158
| +1% | +$6.85K | 0.02% | 945 |
|
|
2020
Q3 | $653K | Sell |
11,840
-298
| -2% | -$16.4K | 0.03% | 691 |
|
|
2020
Q2 | $766K | Buy |
12,138
+1,783
| +17% | +$113K | 0.04% | 557 |
|
|
2020
Q1 | $529K | Sell |
10,355
-335
| -3% | -$17.1K | 0.01% | 881 |
|
|
2019
Q4 | $850K | Buy |
10,690
+1,035
| +11% | +$82.3K | 0.02% | 877 |
|
|
2019
Q3 | $468K | Sell |
9,655
-117
| -1% | -$5.67K | 0.01% | 1073 |
|
|
2019
Q2 | $514K | Buy |
9,772
+1,804
| +23% | +$94.9K | 0.01% | 1057 |
|
|
2019
Q1 | $422K | Buy |
7,968
+648
| +9% | +$34.3K | 0.01% | 1084 |
|
|
2018
Q4 | $300K | Buy |
+7,320
| New | +$300K | 0.01% | 1174 |
|
|
2018
Q3 | – | Sell |
-7,624
| Closed | -$345K | – | 1660 |
|
|
2018
Q2 | $345K | Buy |
7,624
+2,420
| +47% | +$110K | 0.01% | 1235 |
|
|
2018
Q1 | $251K | Buy |
+5,204
| New | +$251K | 0.01% | 1322 |
|